LGC announces changes to its Executive Leadership Team

News - These changes follow recent strong trading performance and further strategy endorsement by Cinven and Astorg, LGC’s new shareholders.

17 June 2020
The importance of standardisation of diagnostic measurements in the COVID-19 pandemic

Blog - Dr Jim Huggett, Principal Scientist at the NML at LGC, recently answered some of our questions around why standardised measurement is so important to medicine.

02 July 2020
LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

09 July 2020
LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

15 July 2020
LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

28 July 2020
LGC releases SARS-CoV-2 & influenza multiplexed molecular quality solutions

News - Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution

29 September 2020
LGC signs pre-let for new R&D facility at Oxford Technology Park

News - Site will accommodate mixture of bespoke laboratory, office and logistics operations

10 November 2020